Results 181 to 190 of about 21,990 (200)
Some of the next articles are maybe not open access.
Oncolytic Virotherapy and the Tumor Microenvironment
2017Oncolytic viral therapy is a promising approach to treat many malignancies, including breast, colorectal, hepatocellular, and melanoma. The best results are seen when using "targeted and armed" viruses. These are viruses that have been genetically modified to selectively replicate within cancer cells and express specific transgenes that alter the tumor
Sara E, Berkey +2 more
openaire +2 more sources
Immunomodulation in Oncolytic Measles Virotherapy
2019With the recognition of oncolytic virotherapy as an immunotherapy, the distinct interactions between oncolytic agents and the immune system have come into focus. The role of the immune system in oncolytic virotherapy is somewhat ambiguous: While preexisting or arising immunity directed against viral antigens may preclude efficient viral replication and
Laura, Dietz, Christine E, Engeland
openaire +2 more sources
Oncolytic Virotherapy-Mediated Anti-Tumor Response: A Single-Cell Perspective
Cancer Cell, 2021Christian Beisel +2 more
exaly
A Critical Virus Production Rate for Efficiency of Oncolytic Virotherapy
European Journal of Applied Mathematics, 2021Youshan Tao
exaly
Oncolytic Virotherapy for Malignant Gliomas
Journal of Clinical Oncology, 2018Peter A, Forsyth, Daniel, Abate-Daga
openaire +2 more sources
Promising OS with oncolytic virotherapy
Nature Reviews Clinical Oncology, 2022openaire +2 more sources
Oncolytic Virotherapy: A Contest Between Apples and Oranges
Molecular Therapy, 2017Stephen J Russell, Kah-Whye Peng
exaly
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Cell, 2017Anthony J Olszanski +2 more
exaly
Global Dynamics of Reaction-Diffusion Oncolytic M1 Virotherapy With Immune Response
Applied Mathematics and Computation, 2020Ahmed Elaiw
exaly

